28 Leading Genomics Companies Shaping Innovation and Market Growth to 2030

The global genomics market is projected to reach $85.09 billion by 2030 from $47.07 billion in 2025, registering a CAGR of 12.6%. This growth is fueled by increasing government funding for large-scale population genomics, the rising prevalence of hereditary disorders, and breakthroughs in Next-Generation Sequencing (NGS) platforms.

Technological convergence is a major trend, with Artificial Intelligence (AI) and Machine Learning revolutionizing data interpretation and variant calling. The following 28 industry leaders are driving these advancements across diagnostics, drug discovery, and agriculture.

1. THERMO FISHER SCIENTIFIC INC.

Thermo Fisher maintains a dominant market position with a comprehensive portfolio of sequencing platforms, genetic analyzers, and consumables. Their Ion Torrent Genexus System provides an automated specimen-to-report workflow, significantly reducing the time to results for clinical and research labs.

2. ILLUMINA, INC.

As a global leader in genome sequencing, Illumina provides the foundational technology for much of the industry. Their high-throughput systems, such as the NovaSeq series, continue to drive down the cost of whole-genome sequencing, making precision medicine more accessible worldwide.

3. DANAHER CORPORATION

Danaher operates in the genomics space through its Life Sciences and Diagnostics subsidiaries, including Integrated DNA Technologies (IDT), Cepheid, and Beckman Coulter. These entities provide critical tools for sample preparation, nucleic acid purification, and automated molecular testing.

4. F. HOFFMANN-LA ROCHE LTD.

Roche is a pioneer in integrating diagnostics and pharmaceuticals. Their focus on companion diagnostics and NGS-based clinical testing ensures that genomic insights are directly translated into personalized treatment strategies for oncology and infectious diseases.

5. AGILENT TECHNOLOGIES, INC.

Agilent’s Diagnostics and Genomics segment specializes in tools for NGS library preparation, microarrays, and molecular testing. They are recognized for high-accuracy analytical instrumentation that supports both clinical research and pharmaceutical quality control.

6. QIAGEN

Qiagen excels in "Sample to Insight" solutions, offering molecular diagnostics platforms and robust bioinformatics tools. Their solutions are widely used for hereditary variant interpretation and clinical NGS testing across a global network of hospitals and laboratories.

7. REVVITY

Formerly part of PerkinElmer, Revvity focuses on automated benchtop systems for NGS library preparation and high-throughput screening. Their technologies support life sciences research and clinical diagnostics with an emphasis on workflow efficiency.

8. LABORATORY CORPORATION OF AMERICA HOLDINGS

Labcorp leverages its massive clinical laboratory network to integrate genomics into routine healthcare. They provide extensive genomic testing services that support clinical trials and patient management across various therapeutic areas.

9. IQVIA INC.

IQVIA applies advanced analytics and real-world data to the genomics sector, helping pharmaceutical companies optimize drug development and commercialization. Their focus on Precision Medicine enables more effective patient stratification in clinical trials.

10. CHARLES RIVER LABORATORIES

Charles River Laboratories provides essential research models and services for genomics-driven drug discovery. Their expertise in preclinical testing supports the development of novel gene therapies and targeted treatments.

11. BIO-RAD LABORATORIES, INC.

Bio-Rad is a leader in life science research and clinical diagnostics, providing instruments and reagents for Droplet Digital PCR (ddPCR). This technology is vital for the precise quantification of DNA and RNA in oncology and rare disease research.

12. EUROFINS SCIENTIFIC

Eurofins offers an international network of laboratory services, including custom DNA sequencing and automated RNA isolation. Their global infrastructure supports large-scale genomic projects and environmental testing.

13. PACBIO

Pacific Biosciences (PacBio) is a leader in long-read sequencing technology. Their systems provide high-resolution insights into complex genomic regions, which are essential for identifying structural variations and assembling de novo genomes.

14. OXFORD NANOPORE TECHNOLOGIES PLC.

Oxford Nanopore offers unique, scalable sequencing technology based on nanopores. Their portable devices enable real-time genomic analysis in diverse settings, from clinical labs to remote field locations.

15. TAKARA BIO INC.

Takara Bio provides a wide range of reagents and kits for molecular biology, including advanced tools for cDNA synthesis and gene expression analysis. Their products are staples in academic and commercial genomics research labs.

16. BGI GROUP

BGI Group is one of the world's largest genomics organizations, driving innovation through its proprietary sequencing technologies and massive data processing capabilities. They are a major force in population-scale genomics and agricultural research.

17. EPPENDORF SE

Eppendorf provides high-quality laboratory equipment, including automated liquid handling systems and thermal cyclers that are essential for standardized genomic workflows and sample preparation.

18. MERCK KGAA

Merck KGaA (operating as MilliporeSigma in the US and Canada) provides essential chemicals, reagents, and technologies for the entire genomics workflow, from sample preparation to gene editing with CRISPR/Cas systems.

19. BD

Becton, Dickinson and Company (BD) integrates flow cytometry and single-cell analysis into the genomics market. Their technologies allow researchers to analyze gene expression at the individual cell level, providing deeper insights into immunology and oncology.

20. ABBOTT

Abbott is a leader in molecular diagnostics, offering a variety of genomic-based tests for infectious diseases and oncology. Their platforms focus on rapid, accurate testing in clinical settings.

21. 10X GENOMICS

10x Genomics is a pioneer in spatial genomics and single-cell technologies. Their platforms enable researchers to understand the biological complexity of tissues by mapping gene expression within its spatial context.

22. NEW ENGLAND BIOLABS

New England Biolabs (NEB) is a recognized leader in the discovery and production of enzymes for molecular biology research. Their high-quality reagents are critical for library preparation in NGS and other genomic applications.

23. PROMEGA CORPORATION

Promega provides innovative technologies for DNA and RNA extraction, as well as bioluminescent assays that support drug discovery and genetic identity testing.

24. CREATIVE BIOGENE

Creative Biogene has distinguished itself among smaller players with a strong product portfolio in viral genome characterization and gene editing services.

25. NOVOGENE CO., LTD.

Novogene is a leading provider of genomic services and solutions, offering high-throughput sequencing and bioinformatics analysis to support clinical research and agriculture globally.

26. HELIX, INC.

Helix focuses on population-scale genomics, partnering with health systems to integrate genomic data into routine clinical care for thousands of patients.

27. PHALANX BIOTECH GROUP

Phalanx Biotech provides specialized microarray and NGS services, supporting researchers with customized genomic analysis for drug development and diagnostic studies.

28. POLARIS GENOMICS

Polaris Genomics specializes in the development of precision medicine tools for behavioral health, utilizing genomic insights to improve the diagnosis and treatment of conditions like PTSD.

Conclusion: Unlock the Full Genomics Market Intelligence

The genomics market's future is defined by its transition from a specialized research field to an essential pillar of routine clinical care and industrial biotechnology. To explore in-depth trends, technology-specific analysis, and geographic segmentation, access the full Genomics Market by Product, Services, Technology, Study Type, Application - Global Forecast to 2030 report now.